chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Weeks after the Pfizer booster I started having blurred vision. I moved and months later was diagnosed with Macular Degeneration. Blood vessels had ruptured and caused blood leakage in my eyes. I asked the Dr. if a COVID shot could have caused it and he said no. However I am filling out this form to see if others have had the adverse effect shortly after the vaccination.
Mild headache began a couple hours after vaccine administered, coupled with mild fatigue.  12 hours after receiving vaccine, moderate headache, moderate fatigue, and vomiting (twice in 10 minutes). 18 hours after receiving vaccine, mild headache. 22  hours after receiving vaccine only adverse symptom is slightly sore arm.
Information has been received from a physician concerning an 18 months old female with no pertinent medical history and no drugs reactions or allergies who in May 1988, was vaccinated with a dose of MUMPSVAX II (Jeryl Lynn) (lot number unknown) (Manufacturer unknown). The physician stated the patient reported that when she was 18 months old she received MUMPSVAX II (Manufacturer unknown) and experienced inflammation of the hip and was hospitalized. The physician stated she had not further information. The physician also reported that as of 26-OCT-2010, the patient had a negative mumps titer. The patient was concomitantly taking birth control pills (Therapy unspecified). At the time of report, the patient's outcome was unknown. Additional information has been requested.
Nose is runny; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHEA (Nose is runny) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RHINORRHEA (Nose is runny). At the time of the report, RHINORRHEA (Nose is runny) had not resolved.            No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Per mother 2 hours after injection behavior changes, unaware of surrounding. Pt went to ER. In 4 days.   pt returned to ER Blood test and MRI were done Per mom everything was normal. Pt discharged 8/28/07.  09/25/2007 MR received for DOS 8/23/2007 for D/C DX of Disorientation, weakness resolved and additional records for 8/24-28/07.  Pt presented to ER x 2 with mental status changes, confusion, and dizziness. Was D/C after all labs were normal.  Increasing fatigue and weakness in the BLEs resulted in return to ER. Confusion was improved at this time. PE shows 4/5 LE stength. Otherwise WNL. Neuro attending reports hx and exam not suggestive of severe neuro complication. Disorientation c/w orthostasis, improved with IVF. Discharged 8/27/07 in improved condition with normal exam.
Patient presented with an syncopal episode.  During admission, patient stated that he was feeling sick for the past few days with chills, nasal congestion, and generalized weakness. The patient was discharged in good health.
This case was reported by a physician via call center representative and described the occurrence of tingling in a 55-year-old female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced tingling. On an unknown date, the outcome of the tingling was recovered/resolved. It was unknown if the reporter considered the tingling to be related to SHINGRIX. Additional information received as follows: The age at vaccination was not reported. The physician reported that the patient experienced tingling in her face following SHINGRIX. The patient drove to the emergency room but felt better on arrival and did not go in. No further details were available to the reporter. The reporter gave consent to follow up.
A non-serious spontaneous report of administration of expired FLUMIST and administration of FLUMIST to 55-year-old female was received from a registered nurse. The patient's medical history and concomitant medications were not reported. The patient received FLUMIST on 31-Aug-2009 or 01-Sep-2009. The product expired in Apr-2009. The patient was re-vaccinated with the "flu shot" on an unspecified date. On 15-Oct-2009, the reporter confirmed there was no adverse event associated with the medication errors; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the events are considered resolved. Additional information was received on  15-Oct-2009 and incorporated into the narrative: confirmed the patient did not experience any adverse events associated with the medication error and the patient was re-vaccinated with the "flu shot."
knot underneath; started to feel pain in that area; red; swollen; pain is severe; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (started to feel pain in that area), VACCINATION SITE ERYTHEMA (red), VACCINATION SITE SWELLING (swollen), VACCINATION SITE PAIN (pain is severe) and VACCINATION SITE MASS (knot underneath) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included DULAGLUTIDE (TRULICITY), METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE MONOHYDRATE (JANUMET), CLOPIDOGREL BISULFATE (PLAVIX), LEVOTHYROXINE, HYDROCHLOROTHIAZIDE, Amitryptiline, LAMOTRIGINE, MIDODRINE, DESVENLAFAXINE, DIAZEPAM, OXYCODONE, TIZANIDINE, CETIRIZINE, METOPROLOL, PREGABALIN, PREGABALIN (LYRICA) and PANTOPRAZOLE for an unknown indication.    On 28-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jun-2021, the patient experienced VACCINATION SITE PAIN (started to feel pain in that area), VACCINATION SITE ERYTHEMA (red), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE PAIN (pain is severe). On 10-Jun-2021, the patient experienced VACCINATION SITE MASS (knot underneath). The patient was treated with IBUPROFEN at a dose of UNK dosage form. At the time of the report, VACCINATION SITE PAIN (started to feel pain in that area), VACCINATION SITE ERYTHEMA (red), VACCINATION SITE SWELLING (swollen), VACCINATION SITE PAIN (pain is severe) and VACCINATION SITE MASS (knot underneath) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant: OTC vitamins Treatment  Ice pack
developed shingles; She is still with some itches; but everything is dry; This case was reported by a nurse and described the occurrence of shingles in a 75-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included pain (Patient is not immunocompromised but she takes severals pills for example, opioid for pain).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced shingles, pruritus and dry skin. On an unknown date, the outcome of the shingles, pruritus and dry skin were unknown.   It was unknown if the reporter considered the shingles, pruritus and dry skin to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix in September 2020 or earlies october 2020 no info about date due it was in a pharmacy and after that, patient developed shingles and was still with some itches but everything was dry. The reporter consented to follow up. There was no data available about lot number or expiration date from Shingrix first dose and HCP not had the exact date about that shot.
First few days nothing besides arm pain. 1/1/2021- to present 1/4/2021 headache, nausea, vommiting, feeling feverish and chills.
Patient stated she can not move her arm from flu shot, she said it got better about 4 days after the shot then got worse. She went to MD and they referred her to another doctor for further evaluation.
Severe headache with nausea.  Cognitive impairment (forgetting important meetings with clients, unable to complete documents pertaining to work.)  Continuing at this time of making the report.
I developed severe joint pain in my hips and knees. I had knee arthritis previously but it seemed to be exacerbated afterwards. I am unsure if its related but wanted to note it. Ankle pain was minimal.
I went to the store and was given the flu vaccine shot by a male pharmacist. I was properly seated on a chair with my left shoulder showing properly, however, immediately he inserted the needle in my left arm, i felt a sharp pain and knew instinctively that he inserted the needle in the wrong place, too low and too far to the back of my left arm. The pain intensified as he ejected the contents of the syringe in my arm and  I told him that it was very painful but he assured me that the pain would ease after a few days. The pain never eased since that day till now, instead the pain got progressively worse.  After a few weeks of continued and worsening pain, on March 31, 2021, I went to consult my primary doctor and she told me I had frozen shoulder from the flu shot. She prescribed steroids for me and gave me at-home exercise to do. After several months, my arm did not get better, but got worse. I lost range of motion in my left arm and cannot perform everyday tasks as before. My left arm has gotten progressively worse. The pain is excruciating and I cannot perform everyday tasks that I was used to before I took the flu shot on December 31, 2020. As the pain and loss of motion continued,in my left arm, I consulted my primary doctor again in August 2021 and she ordered an MRI for me. The MRI result indicate that I have fluid in my left shoulder joint, as well as inflammation and swelling in my left shoulder tendon and ........... As a result, my primary doctor referred me to an Orthopedic doctor to continue treatment. At my fist visit with the doctor on August 20, 2021, the doctor confirmed my injury, gave me an injection at the back of my left shoulder and gave me at-home therapy exercises to do for a month, after which I will see him again on September 24, 2021. I am perplexed and have lost many days of work and spent money on fixing my shoulder. I cry out in anguish when my left arm starts throbbing. The loss in range in motion is of great concern to me as I am not able to lean on my left elbow, cook, bath, properly dress and undress myself, open my car door, use drive-through, etc. I am currently undergoing physical therapy at an out-patient physical therapy facility.
Janssen COVID-19 Vaccine  I felt okay until 2:30.  I started to get very bad body aches and the chills, later on  I developed a headache and I couldn?t move out of bed because I felt so sick. My temp reached 102 at 8:15 even after taking a 500mg tylenol earlier. I had to stay sitting up because I got nauseous when I tried to lay down completely.  I also kept getting very hot then very cold. It?s 4/13 and I?m feeling a bit better but still feel kinda weak and get exhausted easily.
Patient reports difficulty with headaches and spiking blood pressure since receiving vaccine.  Symptoms have started on and off ever since receiving vaccine on 6/8/2021.  Headaches have become severe 3 or 4 times a day over the course of the last several days.  She has followed up with her primary care provider who recommends alternating tylenol and motrin and follow up in office if no improvement on Friday, June 18, 2021
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2015, the patient was inoculated with ZOSTAVAX at a pharmacy as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of herpes zoster. On or about 15-JUL-2016, the patient was treated by a physician for a vesicular outbreak which was diagnosed as shingles. She was prescribed acyclovir for management of her painful symptoms and chronic pain. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
Evening 1(3/7/2022): Muscle soreness all over, fever, cannot sleep.  Day 2 (3/8/2022): Extreme fatigue, swollen eyes, strong chest pain and lower back pain No time for treatment, I had to work, and my employer required me to get the booster.
Shaky and weak legs and hands; Balance and coordination poor; Extreme fatigue; Head pressure; Stomach distress.
pt recvd HIB on 20AUG92 @ 230PM; 21AUG92 t99 ax; pt recvd APAP-slept well; 22AUG92 830AM pt blue, uncertain of breathing, eyes rolled to side; ambulance taken to ER; lt sided twitching in ambulance; blood work OK; ears clear; t101;
swollen; sore; site of the injection is itchy; more red and swollen and bigger and itchy/one arm looks a lot bigger than other arm; red around injection; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swollen), PAIN (sore), VACCINATION SITE PRURITUS (site of the injection is itchy), LIMB DISCOMFORT (more red and swollen and bigger and itchy/one arm looks a lot bigger than other arm) and VACCINATION SITE ERYTHEMA (red around injection) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SWELLING (swollen), PAIN (sore), VACCINATION SITE PRURITUS (site of the injection is itchy), LIMB DISCOMFORT (more red and swollen and bigger and itchy/one arm looks a lot bigger than other arm) and VACCINATION SITE ERYTHEMA (red around injection). At the time of the report, SWELLING (swollen), PAIN (sore), VACCINATION SITE PRURITUS (site of the injection is itchy), LIMB DISCOMFORT (more red and swollen and bigger and itchy/one arm looks a lot bigger than other arm) and VACCINATION SITE ERYTHEMA (red around injection) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported. Treatment included use of ice.
I woke up with a sore throat and a high fever and took a COVID-19 test that was positive. I took a prescription of PAXLOVID.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or around 14-JAN-2014, the patient was vaccinated with ZOSTAVAX (dose, route of administration, lot # and expiration date were not specified) for its intended purpose: the prevention of shingles. As a direct result of the vaccine, patient suffered from a Shingles outbreak, in addition to chronic pain, rash and lesions to various parts of his body. The patient did not have a Shingles outbreak until 01-NOV-2014. As a direct result of the vaccine, the patient suffered mental and emotional distress due to resulting physical limitations, scaring and seriousness of his condition and continues to suffer and endure the expenses of life long medications. As a result of ZOSTAVAX, the patient sustained severe and permanent personal injuries. Further, as a tragic consequence of ZOSTAVAX, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. Shingles outbreak and scarring were considered to be disabling. Additional information has been requested.
Very irritable after vax. Later briefly unattended in stroller - mother touch child "grey" but breathing - color responded to picking him up. No sx since.
Pt complained of "shooting, tingling" pain in left arm from site of administration to fingertips. Pt briefly lost consciousness but quickly returned to awareness with minimal intervention. Throughout remainder of day the pt continued to display periods of lightheadedness and pain in affected arm.  At approximately 1420 the pt had a prolonged period of delirium but was able to respond appropriately to verbal commands. Vital signs at this time were within normal limits, PERRLA 4mm bilat, moving all extremities with equal strength. Pt was transported to a local ER via EMS for further evaluation.
Itchiness and swelling at Injection site; Itchiness and swelling at Injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchiness and swelling at Injection site) and VACCINATION SITE SWELLING (Itchiness and swelling at Injection site) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itchiness and swelling at Injection site) and VACCINATION SITE SWELLING (Itchiness and swelling at Injection site). At the time of the report, VACCINATION SITE PRURITUS (Itchiness and swelling at Injection site) and VACCINATION SITE SWELLING (Itchiness and swelling at Injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications included.  Cold Pack, cortisone cream, alcohol swab are added as treatment medications.
I took a nap and now I can not move my head without my ear hurting anytime she moves significantly she has sharp pain
Vomited 2 hours after receiving vaccine then began with a headache.  Still has a headache 2 weeks later.
Pt. developed swelling (firm) below Left clavicle, about fig size per parent, swelling now smaller in size. Left infraclavicular lymph node enlargement Post vaccination
Severe headache, earache, body aches, sweats, and chills with fever, nausea, and vomiting from approximately 6pm night of shot until 2:00pm next day.
pain at the injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a elderly male patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season at an unknown dose. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown.   It was unknown if the reporter considered the injection site pain to be related to Influenza vaccine Quadrivalent unspecified season.  Additional case details were reported as follows: The age at vaccination was not reported. The patient was over the age of 70. No additional details were available. The reporter did not consent to follow up.
feels dizzy; feels very weak; feels very sick; having an allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (feels dizzy), ASTHENIA (feels very weak), VACCINATION COMPLICATION (feels very sick) and VACCINATION COMPLICATION (having an allergic reaction) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history provided by reporter.  Concomitant products included OLOPATADINE HYDROCHLORIDE (PATANOL) for an unknown indication.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jan-2021, the patient experienced DIZZINESS (feels dizzy), ASTHENIA (feels very weak), VACCINATION COMPLICATION (feels very sick) and VACCINATION COMPLICATION (having an allergic reaction). At the time of the report, DIZZINESS (feels dizzy), ASTHENIA (feels very weak), VACCINATION COMPLICATION (feels very sick) and VACCINATION COMPLICATION (having an allergic reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medication also included medication for allergies at an unknown dose and frequency via an unknown route.  No treatment medication information provided. Laboratory details was not provided.  Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Some Liquid Vaccine leaked out of the Injection Site; Small Redness Injection Site; Bump Injection Site; Itching Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTRATION ERROR (Some Liquid Vaccine leaked out of the Injection Site), VACCINATION SITE ERYTHEMA (Small Redness Injection Site), VACCINATION SITE MASS (Bump Injection Site) and VACCINATION SITE PRURITUS (Itching Injection Site) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced PRODUCT ADMINISTRATION ERROR (Some Liquid Vaccine leaked out of the Injection Site), VACCINATION SITE ERYTHEMA (Small Redness Injection Site), VACCINATION SITE MASS (Bump Injection Site) and VACCINATION SITE PRURITUS (Itching Injection Site). At the time of the report, PRODUCT ADMINISTRATION ERROR (Some Liquid Vaccine leaked out of the Injection Site), VACCINATION SITE ERYTHEMA (Small Redness Injection Site), VACCINATION SITE MASS (Bump Injection Site) and VACCINATION SITE PRURITUS (Itching Injection Site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.